Provisional Program as of Feb. 7, 2015

 ANNUAL MeTA PHILIPPINES FORUM
The Bayleaf Intramuros, Muralla corner Victoria Streets, Intramuros Manila 1002
17-18 February 2015, 9:00 a.m. – 5:00 p.m.
WALKING THE TALK: A LEGACY OF BETTER HEALTHCARE FOR THE FILIPINO PATIENT PROVISIONAL PROGRAM
DAY 1: 17 FEBRUARY 2015 (TUESDAY)
9:00 – 9:10
9:10 – 9:20
9:20 – 9:40
9:40 – 10:00
10:00 – 10:40
10:40 – 10:45
10:45 – 11:15
11:15 – 12:15
SESSION 1
OPENING OF THE 2015 FORUM
ACCESS AND EQUITY: MAKING HEALTHCARE A REALITY FOR ALL
Invocation
Ms. Precy Declaro-Deluria
Executive Director, Philippine Cerebral Palsy, Inc.
Philippine National Anthem
Introduction to MeTA in the Philippines
Opening Message
Mr. Roberto M. Pagdanganan
Chairman, MeTA Philippines
Remarks from the International MeTA Secretariat
Ms. Deirdre Dimancesco
Technical Officer - Department of Essential
Medicines, World Health Organization
Messages of the Guest Speakers
Overview of the Forum
Dr. Tim Reed
Executive Director, Health Action International
Acting Sec. Janette L. Garin, MD (invited)
Department of Health
Dr. Julie Lyn Hall, MBE
WHO Representative to the Philippines
Ms. Cecilia C. Sison
Country Coordinator, MeTA Philippines
SESSION 2
EMPOWERMENT: ENGAGING PATIENTS IN THE DIALOGUE ON HEALTH
Presentation
Mr. Wadel S. Cabrera III
Stakeholder Mapping and Development of a
WHO / MeTA Project Consultant
Framework for the Engagement and Empowerment
of Patient Organizations in the Philippines
Panel Discussion
Asst. Sec. Paulyn Jean R. Ubial, MD (invited)
Head, Office for Technical Services
Moderator: Dr. Noel R. Juban
Department of Health
Professor, University of the
Dr. Maria Minerva P. Calimag
Philippines College of Medicine
President, Philippine Medical Association
Mr. Teodoro B. Padilla
Executive Director, Pharmaceutical and Healthcare
Association of the Philippines
Engr. Emer Rojas
President, New Vois Association of the Philippines
Dr. Benjamin Bernardino
Secretary General, Life Haven Independent
Living Center
Ms. Salvacion Basiano
President, Center for Empowerment and
Development of the Elderly and Seniors
12:15 – 12:35
12:35 – 12:45
12:45 – 2:00
Open Forum
Group Photo Session
Lunch
SESSION 3
MULTISTAKEHOLDER COLLABORATION: HEALTH AND MEDICINES FOR THE FILIPINO PATIENT
Panel Discussion – Part 1 (Access to Medicines)
2:00 – 3:20
Drug Price Watch / Electronic Drug Price Monitoring
System (EDPMS) / Drug Price Reference Index
(DPRI)
Dr. Anna Melissa S. Guerrero
Program Manager, National Center for
Pharmaceutical Access and Management
Department of Health
Rational Use of Medicines (RUM) Framework /
Antimicrobial Resistance (AMR) Policy
Dr. Irene F. Farinas
Division Chief, National Center for Pharmaceutical
Access and Management
Department of Health
Combating SSFFC (substandard, spurious, falselylabeled, falsified, counterfeit) medical products /
Coalition for Safe Medicines
Ms. Maria Lourdes C. Santiago, RPh (invited)
Director, Center for Drug Regulation and Research
Food and Drug Administration
Pharmaceutical Transparency Through Technology
(PTTT) / LUNAS mobile app
Dr. Bryan Albert Lim
Founding Partner, Health Sector Catalyst
Panel Discussion – Part 2 (Financing)
3:20 – 3:40
3:40 – 3:45
3:45 – 5:00
Tamang Serbisyo para sa Kalusugan ng Pamilya
(TSeKaP) / Z Benefits
Dr. Francisco Z. Soria, Jr. (invited)
Vice President, Quality Assurance Group
Philippine Health Insurance Corporation
Local government initiatives to address medicine
needs of its constituents and the community
Hon. Gerardo V. Calderon (invited)
Mayor, Municipality of Angono, Rizal
Financing medicine needs of the poor through
programs of the Philippine Charity Sweepstakes
Office (PCSO)
Atty. Ferdinand M. Rojas II (invited)
Chairman / General Manager
Philippine Charity Sweepstakes Office
Moderator: Mr. Tomas Marcelo Luke G. Agana III
Adviser, Philippine Chamber of
the Pharmaceutical Industry
Open Forum
SESSION 4
STAKEHOLDER PERSPECTIVES
Introduction to the Stakeholder Workshops
Stakeholder Workshops
Group Facilitators
Mr. Ralph Emerson P. Degollacion
Moderator: Ms. Cecilia C. Sison
Dr. Irene F. Farinas
Country Coordinator
Mr. Manuel Alexander Haasis
MeTA Philippines
Dr. Elenita Loida A. Pedrosa
Ms. Karen A. Villanueva
DAY 2: 18 FEBRUARY 2015 (WEDNESDAY)
9:00 – 9:05
9:05 – 10:05
10:05 – 10:35
10:35 – 11:05
11:05 – 11:35
11:35 – 1:20
1:20 – 1:50
SESSION 5
SHARING STAKEHOLDER INSIGHTS
Invocation
Ms. Maria Zenaida J. Averilla
Founder / CEO, Scleroderma Society of
the Philippines
Reports on the Day 1 Stakeholder Workshops
SESSION 6
ACCOUNTABILITY: FOLLOWING THE MONEY SPENT ON KEY HEALTH PROGRAMS
Medicines Watch
Dr. Elmer S. Soriano
MeTA / CHAT Project Consultant
Civika Institute
Philhealth Watch
Mr. Rene R. Raya
MeTA / CHAT Project Consultant
Action for Economic Reform
Sin Tax Monitoring Tool
Ms. Marian Theresia R. Valera
Consultant, HealthJustice Philippines
Lunch / Civil Society Meeting with the IMS
Panel Discussion
Asst. Sec. Elmer G. Punzalan, MD (invited)
Head, Office for Health Regulation
Moderator: Mr. Roderick L. Salenga
Department of Health
NPO (EMD)
Ruben John A. Basa
WHO Country Office
Senior Vice President, Health Finance Policy Group
Philippine Health Insurance Corporation
Ms. Teofila E. Remotigue
CEO, National Pharmaceutical Foundation, Inc.
Coalition for Health Advocacy and Transparency
1:50 – 2:15
2:15 – 2:45
2:45 – 3:00
Open Forum
SESSION 7
SUSTAINABILITY: BUILDING ON THE GAINS AND MOVING FORWARD
Response of The Filipino Patient
Mr. Josefino de Guzman
President, Psoriasis Philippines
Synthesis and Closing Remarks
Ms. Maria Fatima G. Lorenzo
President, Philippine Alliance of Patient
Organizations
Mr. Roberto M. Pagdanganan
Chairman, MeTA Philippines
MEETING OF THE MeTA PHILIPPINES COUNCIL AND THE INTERNATIONAL MeTA SECRETARIAT (IMS)
Muralla Ballroom / Mint Function Room, The Bayleaf Intramuros, 3:00 – 5:00 pm
PROVISIONAL AGENDA
1. Call to Order
2. Preliminary assessment of the results of the Annual MeTA Philippines Forum
3. Sustainability Plan for MeTA Philippines
3.1 Results of the Program Sustainability Assessment (IMS, Nov 2014)
3.2 Results of the MeTA Sustainability Assessment Survey (MeTA Philippines, Feb 2015)
3.3 Draft Sustainability Plan
4. Next Steps / Other Matters
5. Adjournment